Stroke & Vascular Disorders
Sneddon syndrome
Apr. 21, 2022
MedLink®, LLC
3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.
An 11-year-old boy suffered from epilepsy with myoclonic absences of unknown (idiopathic) cause since the age of 12-months-old. These episodes were recorded during video-EEG recordings at the age of 11-years-old because he had 3 generalized tonic-clonic seizures. At the age of 12 months, he was noticed to have jerks in upper part of his body (head, upper limbs) mostly induced by noise at a frequency a few per week. These episodes were described as earthquake-like. At the age of 6-years-old he was reported to have about 10 episodes of vague looks concomitant with rhythmic jerking of head and upper limbs daily. These episodes had not responded to high doses of valproate, lamotrigine, clobazam, or levetiracetam. When ethosuximide was introduced to his treatment instead of lamotrigine absence episodes responded but he had for the first time 3 generalized tonic-clonic seizures during which his head and eyes turned left, twisted mouth, clonic-myoclonic movements of upper limbs for few minutes and subsequently did not respond for about 45 minutes. Neurologic assessment revealed no lateralizing signs and the MRI was negative. The episodes were controlled 80% combining valproate and ehtossuximide at optimal daily doses. The family and past history were noncontributory. (Contributed by Dr Athanasios Covanis.)